{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-181528","form_type":"8-K","ticker":"CGEM","cik":"0001789972","company_name":"Cullinan Therapeutics, Inc.","filed_at":"2022-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.330983+00:00","generated_at":"2026-06-24T23:22:04.755320+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Cullinan Oncology shareholders re-elect Gadicke and Rosenberg as directors, ratify KPMG","bullets":["Ansbert Gadicke elected with 27,033,605 votes for, 10,667,725 withheld, 4,141,978 broker non-votes.","Anthony Rosenberg elected with 27,229,454 votes for, 10,471,876 withheld, same broker non-votes.","KPMG ratified as independent auditor for FY2022: 41,825,399 for, 12,030 against, 5,879 abstentions."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-181528","json":"https://secwatch.observer/filing/0001193125-22-181528.json","markdown":"https://secwatch.observer/filing/0001193125-22-181528.md","text":"https://secwatch.observer/filing/0001193125-22-181528.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1789972/000119312522181528/0001193125-22-181528-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1789972/000119312522181528/d516441d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T23:22:04.755320+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}